Lavipharm S.A Tangible Net Worth Ratio
Lavipharm S.A tangible net worth ratio. Lavipharm S.A (LAVI) has a Tangible Net Worth Ratio of 6.2% as of December 2024. This metric is calculated by deducting intangible assets (€49.68 Million) from net assets (€52.97 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check LAVI strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Lavipharm S.A (2022–2024)
Tangible net worth ratio of Lavipharm S.A from 2022 to 2024. This chart shows how Lavipharm S.A's Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of December 2024, the ratio stands at 6.2%, reflecting net assets of €52.97 Million with intangible assets of €49.68 Million EUR. See working capital position of Lavipharm S.A to evaluate short-term liquidity relative to the company's equity base.
Lavipharm S.A Tangible Net Worth Ratio by Year (2022–2024)
Lavipharm S.A tangible net worth ratio by year from 2022 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Lavipharm S.A from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Lavipharm S.A.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 6.2% | €52.97 Million | €49.68 Million | €125.48 Million | ▲ +10.3 pp |
| 2023 | -4.1% | €42.77 Million | €44.54 Million | €114.79 Million | ▲ +10.5 pp |
| 2022 | -14.7% | €40.28 Million | €46.20 Million | €114.17 Million | — |